David N Church - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

David N Church

Showing results (41-50 of 63) with videos related to

Pageof 7

Sort By:

Journal of the National Cancer Institute|December 16, 2014

Prognostic significance of POLE proofreading mutations in endometrial cancerDavid N Church, Ellen Stelloo, Remi A Nout, et al.

The Journal of Pathology|December 13, 2019

Clinicopathological and molecular characterisation of 'multiple-classifier' endometrial carcinomasAlicia León-Castillo, Ester Gilvazquez, Remi Nout, et al.

The Journal of Pathology. Clinical Research|May 14, 2020

Histological phenotypic subtypes predict recurrence risk and response to adjuvant chemotherapy in patients with stage III colorectal cancerAntonia K Roseweir, James H Park, Sanne Ten Hoorn, et al.

Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 17, 2015

POLE Proofreading Mutations Elicit an Antitumor Immune Response in Endometrial CancerInge C van Gool, Florine A Eggink, Luke Freeman-Mills, et al.

Lancet (London, England)|February 3, 2020

Deep learning for prediction of colorectal cancer outcome: a discovery and validation studyOle-Johan Skrede, Sepp De Raedt, Andreas Kleppe, et al.

British Journal of Cancer|March 30, 2021

Promises and challenges of adoptive T-cell therapies for solid tumoursMatteo Morotti, Ashwag Albukhari, Abdulkhaliq Alsaadi, et al.

Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 11, 2018

Frequent Homologous Recombination Deficiency in High-grade Endometrial CarcinomasMarthe M de Jonge, Aurélie Auguste, Lise M van Wijk, et al.

British Journal of Cancer|November 23, 2020

The Glasgow Microenvironment Score associates with prognosis and adjuvant chemotherapy response in colorectal cancerPeter G Alexander, Antonia K Roseweir, Kathryn A F Pennel, et al.

Cancer|April 1, 2021

Evaluation of treatment effects in patients with endometrial cancer and POLE mutations: An individual patient data meta-analysisJessica N McAlpine, Derek S Chiu, Remi A Nout, et al.

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 14, 2024

Prognostic and Predictive Value of Immunoscore in Stage III Colorectal Cancer: Pooled Analysis of Cases From the SCOT and IDEA-HORG StudiesEnric Domingo, Caroline Kelly, Jennifer Hay, et al.

Pageof 7

Search research articles

Showing results (41-50 of 63) with videos related to

Sort By:

Pageof 7

Journal of the National Cancer Institute|December 16, 2014

Prognostic significance of POLE proofreading mutations in endometrial cancerDavid N Church, Ellen Stelloo, Remi A Nout, et al.

The Journal of Pathology|December 13, 2019

Clinicopathological and molecular characterisation of 'multiple-classifier' endometrial carcinomasAlicia León-Castillo, Ester Gilvazquez, Remi Nout, et al.

The Journal of Pathology. Clinical Research|May 14, 2020

Histological phenotypic subtypes predict recurrence risk and response to adjuvant chemotherapy in patients with stage III colorectal cancerAntonia K Roseweir, James H Park, Sanne Ten Hoorn, et al.

Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 17, 2015

POLE Proofreading Mutations Elicit an Antitumor Immune Response in Endometrial CancerInge C van Gool, Florine A Eggink, Luke Freeman-Mills, et al.

Lancet (London, England)|February 3, 2020

Deep learning for prediction of colorectal cancer outcome: a discovery and validation studyOle-Johan Skrede, Sepp De Raedt, Andreas Kleppe, et al.

British Journal of Cancer|March 30, 2021

Promises and challenges of adoptive T-cell therapies for solid tumoursMatteo Morotti, Ashwag Albukhari, Abdulkhaliq Alsaadi, et al.

Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 11, 2018

Frequent Homologous Recombination Deficiency in High-grade Endometrial CarcinomasMarthe M de Jonge, Aurélie Auguste, Lise M van Wijk, et al.

British Journal of Cancer|November 23, 2020

The Glasgow Microenvironment Score associates with prognosis and adjuvant chemotherapy response in colorectal cancerPeter G Alexander, Antonia K Roseweir, Kathryn A F Pennel, et al.

Cancer|April 1, 2021

Evaluation of treatment effects in patients with endometrial cancer and POLE mutations: An individual patient data meta-analysisJessica N McAlpine, Derek S Chiu, Remi A Nout, et al.

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 14, 2024

Prognostic and Predictive Value of Immunoscore in Stage III Colorectal Cancer: Pooled Analysis of Cases From the SCOT and IDEA-HORG StudiesEnric Domingo, Caroline Kelly, Jennifer Hay, et al.

Pageof 7